Medclair AB (NGM:MCLR)
Sweden · Delayed Price · Currency is SEK 2.960
-0.100 (-3.27%)
At close: Sep 3, 2026
Medclair AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 54.13 | 56.07 | 35.95 | 42.42 | 28.17 | 13.32 |
Revenue Growth | 30.73% | 55.96% | -15.25% | 50.60% | 111.49% | 107.70% |
Gross Profit Gross Profit Growth | 34.86 | 38.04 | 23.35 | 24.76 | 20.41 | 7.52 |
Operating Income Operating Income Growth | 2.14 | 5.7 | -6.17 | -2.63 | -3.97 | -12.82 |
Net Income Net Income Growth | 1.48 | 4.65 | -0.66 | -2.79 | -5 | -13.02 |
Earnings Per Share EPS Growth | - | 0.06 | -0.01 | -0.03 | -0.06 | -0.16 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Technology Medical Technology Growth | 52.08 | 28.09 | 31.08 | 16.01 | 5.4 |
Sports Equipment Sports Equipment Growth | - | 4.12 | 8.77 | 8.88 | 5.29 |
Total Total Growth | 52.08 | 32.2 | 39.85 | 24.89 | 10.69 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 18.87 | 5.74 | 2.58 | 3.2 | 3.89 | 20.21 |
Total Debt Total Debt Growth | - | - | - | 0.39 | 0.88 | 1.38 |
Net Cash (Debt) Net Cash Growth | 18.87 | 5.74 | 2.58 | 2.81 | 3.01 | 18.84 |
Net Cash Growth | - | 122.18% | -8.11% | -6.46% | -84.05% | - |
Net Cash Per Share Net Cash Per Share Growth | - | 0.07 | 0.04 | 0.03 | 0.04 | 0.23 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1.44 | 7 | 3.23 | 5.26 | -11.46 | -8.68 |
Capital Expenditures CapEx Growth | -0.09 | -0.09 | -2.04 | -1.03 | -0.31 | - |
Free Cash Flow Free Cash Flow Growth | 1.35 | 6.91 | 1.19 | 4.23 | -11.77 | -8.68 |
Free Cash Flow Growth | - | 480.02% | -71.84% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.40% | 67.85% | 64.94% | 58.38% | 72.46% | 56.45% |
Operating Margin | 3.96% | 10.17% | -17.16% | -6.20% | -14.09% | -96.25% |
Pretax Margin | 2.73% | 8.30% | -1.85% | -6.54% | -17.71% | -97.69% |
Profit Margin | 2.73% | 8.30% | -1.85% | -6.57% | -17.75% | -97.76% |
FCF Margin | 2.48% | 12.32% | 3.31% | 9.97% | -41.79% | -65.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 183.42 | 52.83 | - | - | - | - |
Forward PE | - | 5.51 | 5.51 | 5.51 | 6.46 | - |
P/FCF Ratio | 201.69 | 35.59 | 95.58 | 32.73 | - | - |
PS Ratio | 5.01 | 4.39 | 3.17 | 3.26 | 3.64 | 16.66 |